BRADY CRAFT: Open Payments
NPI 1174041867 · ASHEBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,719 in 104 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $1,107 · 2025 $1,719
Food & beverage: $1,719
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $336 |
| Novo Nordisk Inc | 14 | $244 |
| AstraZeneca Pharmaceuticals LP | 11 | $213 |
| Amgen Inc. | 10 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $143 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $81 |
| Lilly USA, LLC | 3 | $60 |
| Sumitomo Pharma America, Inc. | 2 | $55 |
| Dynavax Technologies Corporation | 3 | $54 |
| Ardelyx, Inc. | 2 | $40 |
Products named: VRAYLAR, Ozempic, CAPLYTA, BREZTRI, JARDIANCE, QULIPTA, UBRELVY, Wegovy.
Industry payments across NC — which companies pay providers there.
